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Background: HCMV encodes a stable 5 kb RNA of unknown function that is conserved across cytomegalovirus
species. In vivo studies of the MCMV orthologue, a 7.2 kb RNA, demonstrated that viruses that do not express the
RNA fail to establish efficient persistent replication in the salivary glands of mice. To gain further insight into the
function and properties of this conserved locus, we characterized the MCMV intron in finer detail.
Methods: We performed multiple analyses to evaluate transcript expression kinetics, identify transcript termini and
promoter elements. The half-lives of intron locus RNAs were quantified by measuring RNA levels following
actinomycin D treatment in a qRT-PCR-based assay. We also constructed a series of recombinant viruses to evaluate
protein coding potential in the locus and test the role of putative promoter elements. These recombinant viruses
were tested in both in vitro and in vivo assays.
Results: We show that the 7.2 kb RNA is expressed with late kinetics during productive infection of mouse
fibroblasts. The termini of the precursor RNA that is processed to produce the intron were identified and we
demonstrate that the m106 open reading frame, which resides on the spliced mRNA derived from precursor
processing, can be translated during infection. Mapping the 5′ end of the primary transcript revealed minimal
promoter elements located upstream that contribute to transcript expression. Analysis of recombinant viruses with
deletions in the putative promoter elements, however, revealed these elements exert only minor effects on intron
expression and viral persistence in vivo. Low transcriptional output by the putative promoter element(s) is
compensated by the long half-life of the 7.2 kb RNA of approximately 28.8 hours. Detailed analysis of viral spread
prior to the establishment of persistence also showed that the intron is not likely required for efficient spread to
the salivary gland, but rather enhances persistent replication in this tissue site.
Conclusions: This data provides a comprehensive transcriptional analysis of the MCMV 7.2 kb intron locus. Our
studies indicate that the 7.2 kb RNA is an extremely long-lived RNA, a feature which is likely to be important in its
role promoting viral persistence in the salivary gland.
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Human cytomegalovirus (HCMV) is a member of the β-
herpesvirus subfamily and a widespread human patho-
gen [1,2]. HCMV infections cause life-threatening illness
in the immunocompromised, including bone marrow
and solid organ transplant recipients, AIDS patients and
patients undergoing cancer chemotherapy. In addition,
HCMV infection of the fetus is the leading cause of vir-
ally induced birth defects, typically presenting as hearing* Correspondence: caroline.kulesza@ucdenver.edu
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stated.loss and developmental deficits that impact over 40,000
newborns annually in the US [3-5].
HCMV infection of healthy, immunocompetent individ-
uals elicits a robust host immune response that effectively
limits virus replication and pathogenesis. Despite this im-
mune response, HCMV has adapted to long-term infec-
tion of humans by balancing persistent replication with
clearance by the immune response. HCMV persistently
replicates in glandular epithelial tissue and eventually es-
tablishes a life-long latent infection of the host. Glandular
epithelial cells, such as those in the salivary gland, are
key sites of HCMV persistent replication in vivo, andl Ltd. This is an Open Access article distributed under the terms of the Creative
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viduals may secrete virus in saliva, breast milk, and urine
for long periods of time following primary infection [2,3].
In order for HCMV to successfully persist, it has evolved
to replicate in cell types where the full replication cycle
elicits little to no cytopathic effect, such as glandular epi-
thelial cells and some types of endothelial cells [6-8]. In
addition, the ability to persistently replicate in the host
likely depends on reduced immune recognition of virus-
infected cells at these specialized sites [9,10]. Few viral de-
terminants that mediate cytomegalovirus persistence have
been identified and little is known about the specific
molecular functions that facilitate persistence. These in-
clude virus-encoded micro-RNAs and a conserved, virus-
encoded G-protein-coupled receptor [11-13]. In addition,
we previously identified a long, non-coding RNA (lncRNA),
expressed by all cytomegaloviruses, that we showed to also
be an important viral determinant of persistence [14].
During lytic replication, HCMV expresses a 5 kb lncRNA
of unknown function (also referred to as RNA5.0) [14-16].
We showed that this RNA is dispensable for replication in
cultured cells and is a stable intron produced by the pro-
cessing of a large precursor transcript expressed from the
genomic region flanked by UL105 and UL111A. Ortho-
logous loci are present in every β-herpesvirus genome
examined thusfar, although there is little conservation of
sequence or RNA size between different CMV species.
Each locus shares some common features, including a high
AT sequence content (~60%), and the presence of many
homopolymeric stretches of A or T residues. The consen-
sus splice donor sequence that defines the 5′ end of the
RNA produced from each locus is also well conserved.
Cytomegaloviruses exhibit strict species specificity and
there is no animal model for HCMV infection. Murine
cytomegalovirus (MCMV) infection of the mouse is widely
used as an outstanding small-animal model of HCMV
infection for several reasons. HCMV and MCMV share
similar genomic sequence and organization and undergo
similar replication cycles [17]. Like HCMV, MCMV
acutely infects multiple tissues in the mouse, persistently
replicates in the salivary gland and establishes a lifelong la-
tent infection of the host [18]. Therefore, MCMV infec-
tion of the mouse is an excellent surrogate for the study of
pathogenesis in vivo. MCMV expresses a 7.2 kb ortholog
of the HCMV 5 kb RNA [19]. We have shown that recom-
binant MCMV that does not express the 7.2 kb RNA
replicates normally in cultured fibroblasts, but is unable to
progress from the acute to the persistent phase of infec-
tion in mice. We identified a short hairpin sequence near
the 3′ end of the intron that is required for accumulation
of the RNA during infection. Persistent replication in the
salivary gland of the mouse depends on the accurate pro-
cessing and stable retention of the intron, since recombi-
nants with a mutation in the splice donor site or deletionof the hairpin sequence fail to transition to the persistent
phase of replication in vivo. The specific molecular function
of this conserved RNA is unknown, but we hypothesize
that it mediates processes essential for the virus to evade
immune surveillance and/or replicate efficiently at sites of
viral persistence.
To gain further insight into the function and proper-
ties of this conserved locus, we characterized the
MCMV intron in finer detail. We confirmed that the
intron locus RNAs are expressed with late gene kinetics.
The 7.2 kb intron has an unusually long half-life,
whereas the spliced mRNA that results from processing
of the intron is metabolized with kinetics similar to most
cellular mRNAs. Investigation of the promoter sequence
that controls expression of the intron locus revealed a
minimal promoter sequence contributing to the tran-
scriptional output of the locus. Although there is no evi-
dence for translation of the intron itself, we discovered
that the spliced mRNA encodes a small protein that
co-localizes with the RNA within the nuclei of infected
cells. Importantly, we show that the RNA is not required
for trafficking of virus to the salivary gland in vivo, sup-
porting our hypothesis that the 7.2 kb RNA functions to
either evade the host response or maintain viral replica-
tion at sites of persistence.
Results
The MCMV 7.2 kb intron locus is transcribed with true
late kinetics
To determine the transcription kinetics of the 7.2 kb in-
tron locus during productive MCMV infection, northern
blot analysis was performed on total RNA prepared from
cells treated with the translation inhibitor cycloheximide
(CHX) or the DNA replication inhibitor phosphonoacetic
acid (PAA) prior to MCMV infection. CHX pre-treatment
of cells inhibits translation of immediate early (IE) genes
blocking subsequent transcription of both early and late
classes of viral genes. PAA treatment blocks DNA replica-
tion, on which expression of late (L) genes is dependent
[1,2]. Transcription of the intron (Figure 1A) and the
spliced mRNA (Figure 1B) was inhibited by both CHX
and PAA treatment. This data indicates that the intron
locus RNAs are transcribed with the late class of viral
genes during productive infection in fibroblasts.
In high resolution northern blot analyses specific for
the intron RNA, we routinely observed a doublet of
bands near 7.2 kb: a major species at approximately
8.0 kb and a minor species migrating faster at 7.2 kb
(Figure 1A). These observations were made with mul-
tiple intron-specific probes (data not shown). We have
been unable to ascertain the basis for this difference in
size, although we hypothesize it may be due to effects of
lariat secondary structure on RNA migration during






















Figure 1 Expression kinetics of intron locus transcripts. Total
RNA was harvested from infected mouse fibroblasts (MOI = 1.0) at
the indicated times and analyzed by northern blot analysis using
radio-labeled, antisense RNA probes specific for (A) the intron or (B)
exon 2 of the spliced mRNA. To determine the kinetics of intron
locus expression, cells were pre-treated with either PAA or CHX for
1 hour prior to infection. Total RNA was prepared at the
indicated times.
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migrating bands in northern blot analyses of the spliced
RNA product of the locus (Figure 1B). We cannot
account for the difference in size based on sequencing
of the 5′ and 3′ Rapid Amplification of cDNA Ends
(RACE) products (see below). It is possible that we did
not capture both species in the RACE reactions but we
think it is likely the differences in size reflect variability
in 3′ end processing and poly-adenylation that we can-
not assess (see Discussion).
Location of transcriptional start sites and RNA
processing signals
While the splice donor and acceptor sites used in the
processing of the 7.2 kb RNA from the primary tran-
script were previously mapped, the termini of the pri-
mary transcript were not determined [19]. To identify
the 5′ and 3′ ends of the primary transcript, we cloned
and sequenced PCR products generated by RACE (sum-
marized in Figure 2A-B). To identify the 5′ end of the
precursor RNA and capture the predicted intron-exon
junctions in the 5′ RACE reaction, we used nested PCR
primers specific for the predicted second exon located 3′
of the intron (primers 541 and 542 Table 1, Figure 2A).
Sequencing of cloned RACE products identified two tran-
scriptional start sites located three nucleotides apart at
positions 161,738 and 161,735 in the MCMV genome(sequence coordinates based on the MCMV Smith strain,
Genbank accession #NC004065). Sequence alignment of
the 5′-RACE products to MCMV genomic sequence also
confirmed the splice donor (SD) and splice acceptor (SA)
sequences at nucleotide positions 161,622 and 154,366, re-
spectively, as previously annotated [19]. We also per-
formed primer extension analysis to confirm the
transcriptional start sites identified by 5′-RACE. We ob-
served two primer extension products of 101 and 104 nu-
cleotides in length, consistent with the location of the 5′
ends of the spliced RNA as defined by RACE (primer 497
Table 1, Figure 2C).
A single 3′ end was identified at nucleotide position
153,872 by sequencing of 3′-RACE products (Figure 2A).
This end is located downstream of a putative polyadeny-
lation signal at position 153,898 (Figure 2B). We also
examined the polyadenylation status of the spliced RNA
by northern blot analysis of oligo(dT)-selected RNA pre-
pared from MCMV-infected cells. The majority of the
spliced mRNA from the intron locus was detected in the
poly A + fraction of RNA (Figure 2D). 18S rRNA can
only be detected in the non-polyadenylated fraction
demonstrating that our fractionation protocol efficiently
captured polyadenylated mRNA only (Figure 2D lanes
A+ and A-). Taken together, our data suggest that a large
precursor RNA is transcribed from the intron locus at
late times of infection and processed to yield a single
7.2 kb stable intron and a spliced poly-adenylated mRNA
consisting of two exons.
The m106 open reading frame on the spliced
mRNA is translated during infection
The second exon of the spliced mRNA processed from
the primary transcript that produces the 7.2 kb RNA
spans a previously annotated open reading frame (ORF)
called m106 [17]. Positional orthologues of m106 have
been identified in all cytomegaloviruses, including the
UL106 ORF of HCMV, yet there is little sequence hom-
ology among the group [20-23]. In general, UL106 ortho-
logues score poorly with algorithms designed to predict
the potential of an ORF to encode a protein [24,25]. To
determine if m106 protein is translated during MCMV
replication we constructed two recombinant viruses engi-
neered to express m106 as a GFP fusion at the carbo
xy-terminus (Figure 3A). The first recombinant virus
expresses the m106-GFP fusion from the wild-type
MCMV genome (MCMV:m106GFP). The second recom-
binant virus expressing the m106-GFP fusion also con-
tains a five-nucleotide substitution at the splice donor site
that defines the 5′ end of the 7.2 kb RNA (MCMVdelSD:
m106GFP) [19]. This substitution prevents processing of
the intron from the primary transcript and we predicted
that it would also prevent translation of m106-GFP pro-


































































Figure 2 Mapping of the intron locus. (A) Diagram of the genomic region encompassing the primary transcript of the 7.2 kb intron, illustrating
the transcriptional start sites (TSS) and the splice donor (SD) and splice acceptor sites (SA). The location of primers used for primer extension or
RLM-RACE are indicated. (B) Diagram of the spliced mRNA and the 5′ and 3′ ends that were identified by RLM-RACE using total RNA harvested
from infected mouse fibroblasts at 48 hours post infection (hpi). Putative TATA box directly upstream of the transcriptional start sites is indicated.
Also shown are the start and stop codons of the m106 ORF encoded on the second exon of the mRNA as well as the poly-adenylation and
cleavage sites used in processing this mRNA. (C) Primer extension analysis was performed on total RNA harvested from either mock-infected (M)
or MCMV (WT) infected mouse fibroblasts at 48 hpi. Radiolabeled primers were used to validate the 5′RLM-RACE products (primer 497) and
confirm the known 7.2 kb splice donor site (primer 50) as a control. (D) Northern blot analysis of total RNA (T) harvested from infected mouse
fibroblasts and fractionated for either polyadenylated (A+) or non-polyadenylated (A-) RNA. The blot was hybridized with a radiolabeled, antisense
RNA probe specific for exon 2.
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blasts (Figure 3B). Immunoblotting for the m106-GFP
fusion protein with antibody specific for GFP only
detected protein expression during MCMV:m106GFP
infection and not MCMVdelSD:m106GFP infection, in-
dicating that splicing of the mRNA is necessary for
translation of m106 (Figure 3C). Furthermore, this data
indicates that cryptic transcriptional initiation does
not appear to occur within the unspliced transcript
produced by MCMVdelSD:m106GFP at any significant
level.
m106 and the 7.2 kb intron localize to the nucleus of
infected fibroblasts
Although we previously demonstrated in fractionation
studies that the HCMV 5 kb intron localizes to the nuclear
compartment of infected cells, the specific sub-nuclearlocalization of the RNA was not examined [14]. Fluores-
cent in situ hybridization (FISH) was used to visualize the
7.2 kb intron in infected mouse fibroblasts. The FISH
staining revealed an even, granular distribution of the
7.2 kb intron throughout the nuclear compartment of in-
fected fibroblasts (Figure 3D). Co-staining for the 7.2 kb
RNA and m106-GFP revealed that the RNA and m106
protein are found co-localizing in the nucleus late during
infection (Figure 3D). We also observed some m106-GFP
protein was localized to the cytoplasm of infected cells.
The MCMV 7.2 kb intron is highly stable
The 7.2 kb RNA accumulates to high levels during infec-
tion as detected by northern blot analysis, suggesting it
is unusually stable for an intron [14,19,26,27]. To quan-
tify transcript stability, we measured RNA decay rates of
intron-locus transcripts during MCMV infection. RNA
Table 1 Primer sequences
















M54 qPCR Fwd: AACATATCCCTGCCGATCTTG
Rev: CAACGCTTTCTACGGTTTCAC
Probe: ATGCTCCCGTGTCTCCCCATC
GAPDH qPCR Fwd: GTGGAGTCATACTGGAACATGTAG
Rev: AATGGTGAAGGTCGGTGTG
Probe: TGCAAATGGCAGCCCTGGTG
Actin B qPCR Fwd: CTTGATCTTCATGGTGCTAGGAG
Rev: CGTTGACATCCGTAAAGACCT
Probe: ACCATGTACCCAGGCATTGCTGA
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Figure 3 The m106 open reading frame is translated during
MCMV infection. (A) Diagram of the GFP cassette insertion within
the MCMV Smith BAC clone. (B) Analysis of recombinant virus
replication in mouse fibroblasts. Cells were infected at a multiplicity
of 0.05 PFU/cell and viral supernatants were collected daily and
titrated. Graph represents two biological replicates. (C) Western blot
analysis of protein lysates prepared from mock-, MCMV:m106GFP
(WT-GFP), or MCMVdelSD:m106GFP (SDM-GFP) infected cells at 48 h
p.i. m106-GFP expression was detected using a polyclonal anti-GFP
antibody. Asterisk denotes m106-GFP. (D) Mouse fibroblasts were in-
fected with MCMV:m106-GFP (MOI = 0.05). Cells were fixed at 72 h p.
i. and m106-GFP protein expression and 7.2 kb intron production
was detected by by combined immunofluorescence assay and FISH.
Schwarz et al. Virology Journal 2013, 10:348 Page 5 of 14
http://www.virologyj.com/content/10/1/348half-lives were quantified by measuring RNA abundance
by quantitative RT-PCR at several time points after
treatment of infected cells with Actinomycin D. This
compound inhibits RNA Polymerase II by intercalating
between GC residues thereby blocking processivity ofthe enzyme. Actinomycin D treatment effectively arrests
transcription of RNA pol II-dependent RNAs and allows us
to measure relative decay rates. Using this strategy, we cal-
culated the half-life of the 7.2 kb intron to be ~28.8 hours
(Figure 4B). In general, the half-life of low-stability RNAs is
typically less than 2 hours whereas long-lived RNAs with
high stability possess a half-life greater than 12 hours [28].
The half-life of the spliced mRNA derived from processing
Intron (a/a’) t1/2 = 28.78 Exon 2 (b/b’) t1/2 = 6.779
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Figure 4 Half-life analysis of the intron locus transcripts. Mouse fibroblasts were infected with MCMV (MOI = 1.0). At 30 hours post infection,
cells were treated with 4 ug/ml of Actinomycin D. Total RNA was harvested over the indicated time course. Intron, mRNA, and 18 srRNA
transcript levels were quantified by qRT-PCR. Intron and spliced mRNA transcripts were normalized to 18 srRNA. The relative quantitative values at
time zero hours were adjusted to 100% and transcript remaining was compared relative to time zero. The fitted curve was modeled by one phase
decay using a non-linear regression analysis on four biological replicates for each time point. The half-life (t1/2) shown for each transcript is the
best-fit value. Bars represent the mean and error bars represent the standard error of the mean (SEM). (A) Schematic representation of primer
probe sets used for qRT-PCR analysis. SD = splice donor sequence, SA = splice acceptor sequence. Half-life decay curves for the (B) 7.2 kb intron
using primer probe set a/a’, (C) the second exon of the mRNA (b/b’), (D) the spliced mRNA using primer probe set c/c’, and (E) GAPDH.
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probe sets: b/b’ targets the second exon and c/c’ spans
the splice junction (Table 1, Figure 4A). We measured a
half-life of ~6.8 hours using the primer-probe set targeting
the second exon (Figure 4C), while a half-life of ~7.8 hours
was measured using the primer-probe set that spans
the splice junction (Figure 4D). This difference may
be accounted for by differences in primer-probe effi-
ciency, processing of the primary transcript, or loca-
tion of the primer-probe sets in relation to protective
secondary structures within the mRNA from degrad-
ation machinery. Both half-lives, however, are consist-
ent with the average half-life for a protein coding RNA.
As a control, we determined the half-life of GAPDH
mRNA to be ~15 hours, similar to published estimates
(Figure 4E) [28]. Our data demonstrates that the
MCMV 7.2 kb intron is, in fact, unusually stable for an
intron RNA.Analysis of minimal promoter sequences
Little data is available regarding the sequence elements
driving late transcriptional units of cytomegaloviruses.
Therefore, the DNA sequence within the vicinity of the
TSSs of the intron locus was examined for transcriptional
regulatory sequences. A putative TATA box element was
identified 24 nucleotides upstream of the transcriptional
start site, as well as an additional TATA box located 127
nucleotides upstream (Figure 2B, Figure 5A). In order to
examine the transcriptional activity of these putative min-
imal promoter elements and the nucleotide sequence sur-
rounding them, DNA sequences from the region between
the intron splice donor site and the M112/113 locus were
cloned into a luciferase reporter plasmid to quantify tran-
scriptional promoter activity (7.2PR1 and 7.2PR2). The
M112/113 locus is located upstream of the intron locus
and on the opposite strand. The transcriptional start site
























































































Figure 5 Analysis of transcriptional activity of putative intron locus promoter elements. (A) Diagram of genomic location of the viral
sequences cloned into pGL3-reporter plasmids. (B) pGL3-reporter constructs were co-transfected into mouse fibroblasts and luciferase induction
was assayed 24 h p.i. following either mock co-infection, (C) UV inactivated co-infection, or MCMV co-infection (MOI = 0.05).
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late promoter was cloned into the reporter vector in both
sense and antisense orientations (M112PR and aM112PR).
To serve as a control, only the M112/113 promoter se-
quence in the sense orientation induced luciferase activity
similar to the control (Figure 5A). Surprisingly, no ap-
preciable induction of luciferase activity was observed
for 7.2PR1 or 7.2PR2 relative to the promoterless control
vector (Figure 5B). We also found that MCMV co-infection
of reporter-tranfected cells did not induce luciferase activity
from the minimal 7.2PR1 promoter construct (Figure 5C).
To examine the contribution of the putative minimal
promoter sequences to transcription of the intron locus
RNAs in the context of virus infection, three recom-
binant viruses were made with deletions in this region
(Figure 6A). We constructed recombinants with (1) a
20 bp deletion spanning the TSS-proximal TATA box,
(2) a 100 bp deletion including the proximal TATA box
and upstream sequence, and (3) a 135 bp deletion span-
ning both the proximal and distal TATA boxes in the
putative minimal promoter sequence. All three recom-
binant viruses replicated similar to wild-type MCMV in
multi-step growth analysis (Figure 6B). We quantified
RNA expression in cells infected with our panel of re-
combinant viruses, including previously characterized
recombinants with mutations that result in a failure to
express significant levels of the intron (MCMVdelHP
and MCMVdelSD) [19]. The MCMVdelHP contains a
28 bp deletion spanning a predicted stem loop structure
at the 3′end of the intron that is hypothesized to confer
stability. Without this stem loop structure, processing ofthe primary transcript still occurs since the mRNA is
detected by qRT-PCR and northern blot analysis, but
accumulation of the intron is significantly reduced
(Figure 6C). While the splice donor site mutation impacts
processing of the precursor transcript and is not expected to
affect transcriptional output of the promoter, we predicted
that MCMVdel135 would reduce overall transcript pro-
duction from the locus. Measured reductions in levels of
the intron were only significant for cells infected with the
MCMVdel135 mutant in addition to the MCMVdelSD and
MCMVdelHP recombinant viruses (Figure 6C). In cells in-
fected with MCMVdel135, intron abundance was reduced
approximately 5-fold while levels of the mature mRNA tran-
script were reduced by 10-fold (Figure 6C,D, and E). Despite
different predicted consequences of the mutations, the re-
duction of the spliced mRNA transcript abundance is similar
between the MCMVdelSD and the MCMVdel135.
To determine if reductions in intron and mRNA ex-
pression have an effect on the establishment of persist-
ence in vivo, mice were inoculated with a subset of our
panel of recombinant viruses and viral yields measured in
the salivary gland at 14 days post-infection (Figure 6F).
We observed a slight reduction in viral yield in the sal-
ivary glands of mice infected with MCMVdel20 and a
ten-fold reduction of viral yield in mice infected with
MCMVdel135. Viral genome quantification corroborated
the measure of infectious virus within the salivary gland
(Figure 6G). However, despite 5–10 fold reductions of in-
tron and mRNA production, neither promoter deletion
mutant fully attenuated persistent replication to the levels
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Figure 6 Deletion mutations in putative viral promoter elements reveal reduction in transcriptional output in cell culture and
decreased recovery of infectious virus in vivo. (A) Diagram of the genomic location of intron locus promoter region deletions. (B) Multi-step
growth analysis of replication of all three recombinant viruses in comparison to WT MCMV. Mouse fibroblasts were infected (MOI = 0.05) and
culture supernatants were collected every 24 hours and titrated by plaque assay. Graph represents three biological replicates. (C, D, and E)
Quantification of intron locus RNAs in cells infected with promoter mutant viruses. Mouse fibroblasts were infected (MOI = 1.0) and total RNA was
harvested 48 hours post infection. Intron locus transcript levels are quantified relative to WT MCMV transcript levels by qRT-PCR. The primer
probes sets used are the same as shown in Figure 4A. Graphs represent three biological replicates. (F and G) Three-month-old female BALB/c
mice were infected with an i.p. dose of 5 x 105 PFU with the indicated viruses. At 14 days post infection, animals were euthanized and tissues
collected for analysis of infectious virus yield (F) and viral genome number (G). (F) Salivary gland homogenates were analyzed by plaque assay
on mouse fibroblasts. p values represent the Student’s T Test result between WT MCMV infected cells or mice and cells or mice infected with the
given recombinant viral mutant for each transcript analyzed (*p < 0.05 **p < 0.01 ***p < 0.001 ****p < 0.0001). WT MCMV =WT; MCMVdel20 = 20DEL;
MCMVdel100 = 100DEL; MCMVdel135 = 135DEL; MCMVdelHP = HPM; MCMVdelSD = SDM.
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the salivary gland
Although we have shown that recombinant viruses that
fail to express the intron replicate poorly in the salivary
glands, it was unclear if this attenuation was caused by a
lack of dissemination to or a failure to replicate within
the salivary gland [19]. To examine whether the intron isrequired for dissemination to the salivary gland, mice
were inoculated with wild-type MCMV or MCMVdelSD
and viral yields in various tissues were measured at 4, 6,
8, and 14 days post infection (Figure 7). MCMVdelSD
replicated to similar levels as wild-type MCMV until
6 days post infection in all tissues examined. At 8 days
post infection, levels of the splice donor mutant virus
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Figure 7 Intron locus RNAs are dispensable for virus dissemination to the salivary glands during acute infection. Three-month-old female
BALB/c mice were inoculated i.p. with 5x105 PFU of WT MCMV or MCMVdelSD. At the indicated days post infection, organs were harvested from
three mice per infection group to quantify infectious virus by plaque assay. Bars represent the mean and error bars represent the standard error
of the mean (SEM). The dashed line indicates the limit of detection.
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but were unchanged in comparison to wild-type MCMV
within the salivary gland and lung. By 14 days post infec-
tion, replication of the splice donor mutant virus was se-
verely attenuated in all organs assayed and infectious
virus was below the limit of detection by plaque assay.
Interestingly, the relative number of MCMVdelSD ge-
nomes was reduced 100-fold in salivary glands at 14 days
post infection relative to wild-type MCMV, suggesting
that the virus was effectively cleared from this tissue
(Figure 8). This data indicates that the intron does not
influence viral dissemination to the salivary gland over a
time course of infection but may function to promote
viral persistence in the glandular epithelial tissue.
Discussion
Non-coding RNAs are known to be expressed by nearly
all herpesviruses that infect humans, yet the function of
these RNAs in viral replication and pathogenesis has
been elusive [15,31-34]. In our current study, we report
further characterization of a lncRNA expressed by
MCMV, the 7.2 kb RNA. This RNA is the ortholog of
the 5.0 kb RNA of HCMV and we have previously
shown that it is a virulence factor that promotes viral
persistence in vivo. We showed that during productive
infection in fibroblasts, the intron locus RNAs are tran-
scribed with true late gene kinetics. These RNAs arederived from a common precursor RNA and are pro-
duced as the result of splicing of two exons that flank
the intron to create a smaller mRNA and the 7.2 kb in-
tron. We observed a doublet of bands with probes spe-
cific for the intron in northern blot analysis at 8.0 and
7.2 kb. While it is formally possible that these represent
two different species of intron, we did not detect evi-
dence of alternative splicing of a larger intron from the
precursor RNA by sequencing of 5′-RACE products.
We think it is likely that the intron remains in the form
of a branched lariat after processing and therefore mi-
grates more slowly during electrophoresis. Similar ob-
servations have been made for the LAT of HSV-1 [35].
We also detected a doublet of bands corresponding to
the spliced mRNA in northern blot analysis. Again,
sequencing of 5′-RACE products did not reveal any
splicing variations that could account for the size differ-
ences. The polyadenylation chain lengths could differ
for the individual spliced mRNA molecules representing
the doublet observed for the mRNA. Identification of
the transcriptional start sites rules out the possibility
that a cluster of miRNAs mapped near to the 7.2 kb in-
tron splice donor site originate from the same primary
transcript [36]. It remains unknown, however, what
functional relationship the miRNAs may have with the
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****
Figure 8 Detection of viral genomes is significantly reduced in salivary glands during persistence. Three-month-old female BALB/c mice
were inoculated i.p. with 5x105 PFU of WT MCMV (WT) or MCMVdelSD (SDM). DNA was harvested from the indicated organs of three mice per
infection group at 14 days post infection and viral genomes were quantified by qPCR using a primer probe set specific for the M54 MCMV gene
and normalized to the beta-actin cellular gene. Bars represent the mean and error bars represent the standard error of the mean (SEM). p values
represent the Student’s T Test result between WT MCMV and MCMVdelSD infected mice (*p < 0.05 **p < 0.01 ***p < 0.001 ****p < 0.0001).
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primary transcript expressed from the intron locus led us
to identify putative transcriptional control elements that
contribute to regulating transcription of the intron precur-
sor. We identified two TATA box elements located within
135 bp of the TSS. However, using a luciferase reporter
system, this region did not confer significant transcrip-
tional activity above background. Transcriptional control
elements driving expression of the adjacent M112/113
locus have been characterized and functioned in our
assay as expected [30]. We were able to rule out the
possibility that the M112/113 promoter controls tran-
scription of the intron locus since function of this pro-
moter is orientation dependent. Intron RNA and
mRNA expression levels in cells infected with recom-
binant virus bearing a deletion spanning the distal and
proximal TATA boxes and transcriptional start site were
reduced compared to wild-type MCMV. However, the
reduction in transcript levels was not nearly as robust
as that observed in recombinants bearing mutations
that affect intron stability or processing. We hypo-
thesize that most of the variations we observed in the
differing effects of promoter mutations on relative in-
tron and mRNA levels can be accounted for by their
different half-lives: since the intron is unusually stable,
it appears to be less affected by the promoter deletions
whereas the mRNA has a shorter half-life and the relativelevels of RNA are more sensitive to modest reductions
in transcriptional output associated with the promoter
deletions.
Our studies did not identify sequence elements that
robustly contribute to transcriptional control of this late
transcriptional unit. As a late gene, amplification of
genome copy number by DNA replication is thought to
be critical for robust L transcription [2]. More recently,
it has been demonstrated that viral replication and L
gene expression also relies on a distinct set of five genes
conserved across beta and gamma herpesviruses: UL79,
UL87, UL91, UL92, and UL95 [37-39]. It is hypothesized
that an RNA polymerase II transcriptional complex in-
cluding one or more of these gene products is assembled
to drive transcription of L genes. MCMV homologs of
HCMV UL87, UL91, UL92, and UL95 have been anno-
tated, but not tested for transcriptional activating func-
tions [38-40]. M79, the MCMV homolog of HCMV
UL79, has been shown to regulate L gene expression, al-
though it does not appear to promote transcription of
the intron locus [41]. It is also possible that we did not
include the sequences responsible for binding of L gene
transactivators within our reporter assay. Clearly, tran-
scriptional regulation of L genes remains largely unex-
plored and it is likely that this process is significantly
different from the activation of immediate early and
early transcriptional units.
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tion of lncRNAs is poorly understood in general. We
demonstrated that the 7.2 kb intron accumulates as a
consequence of a slow decay rate. Different properties
contribute to lncRNA stability include GC content, the
presence of specific decay elements, and if they are
intronic. Given its intronic and AT-rich nature, the
MCMV 7.2 kb lncRNA would be predicted to be highly
unstable since introns are rapidly degraded on formation
and AT-rich sequences do not form strong secondary
structures that might protect the RNA from degradation.
A stem-loop structure located near the 3′ end of the
intron between the polypyrimidine track and putative
branch point was identified using the structural predic-
tion software mFold. Deletion of the stem loop does not
impact processing of the precursor transcript, but does
prevent accumulation of the intron during infection
[19]. We hypothesize that the intron remains in the form
of a lariat, similar to the Latency Associated Transcript
(LAT) of HSV-1, thereby protecting it from degradation
[42,43]. While the sequence and structural determinants
of stability remain largely unknown for the 7.2 kb intron,
its long half-life accounts for its accumulation and could
be a key component of its functionality.
The spliced mRNA produced by processing of the
7.2 kb RNA spans the m106 ORF. Using an epitope-
tagging strategy, we showed that this ORF could be
translated during MCMV infection. The GFP-tagged
protein co-localized to the nucleus of infected cells with
the 7.2 kb RNA. This may reflect a related function of the
intron and the m106 protein. Recombinant viruses that
specifically disrupt m106 expression without impacting
intron production will be useful reagents to probe the
function for this viral protein. The m106 protein and its
orthologues encoded by other CMVs, including UL106
of HCMV, have some unusual properties. Despite not
sharing significant sequence homology, all UL106 ortholo-
gues are small (<150 amino acids), highly basic, arginine-
rich peptides. It is unknown if other UL106 orthologues
are expressed during infection, but given the conservation
of the genomic organization of the intron locus among
CMVs, it is a distinct possibility to be explored.
Production of the 7.2 kb RNA is required for the
establishment of persistence in the salivary glands of mice.
By analysis of multiple time points between the acute and
persistent phases of infection in mice, we showed that re-
combinant virus lacking the intron appears to disseminate
to the salivary gland as efficiently as wild-type MCMV.
However, it is unable to maintain a highly productive repli-
cation program in the salivary glands as observed at 14 days
post infection. In addition, we did not detect infectious
MCMVdelSD in any organs at 14 dpi and genome copy
number of the mutant virus was substantially reduced in
liver and kidney. It is possible that the mechanisms thatprevent establishment of intron-mutant virus persist-
ence in the salivary gland may also promote accelerated
clearance of that virus from liver and kidney. At this
time, the adaptive immune response acts to limit viral
replication and it is possible that the 7.2 kb intron is in-
volved in modulating immune surveillance in some way.
Some cellular lncRNAs are involved in transcriptional
regulatory processes, therefore, a possible mechanism
for evading the immune response could be to regulate
cellular or viral genes that are involved in this host
pathogen relationship [44,45].
Conclusions
This current study has provided a detailed transcrip-
tional and functional analysis of the MCMV 7.2 kb RNA
locus. Mapping the topography of the 7.2 kb RNA locus
allows us to understand the genomic elements that not
only comprise the locus but also control its expression.
The unusual stability of the 7.2 kb RNA compensates
for the weak transcriptional output by the putative pro-
moter region observed and may also provide insight
towards molecular function within the nucleus of in-
fected cells. Uncovering the stability determinants of
the 7.2 kb RNA will therefore allow us to understand
the mechanisms that promote its retention within in-
fected cells. Although a function has yet to be deter-
mined to the 7.2 kb RNA, this current analysis has




10.1-mouse embryonic fibroblasts were propagated in
Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 10% newborn calf serum, 100 U/ml penicil-
lin, and 100 ug/ml streptomycin. Cells were maintained
at 37°C with 5% CO2.
Viruses
The BAC clone of the wild type Smith MCMV strain,
pSM3fr, was used as the parent strain in this study [46,47].
Recombinant viruses were generated by linear recombin-
ation using either the seamless, red-mediated recom-
bination in the DH10B Escherichia coli strain GS1783
method or by using the FLP-recombinase method as pre-
viously described [19]. Primer sequences used to generate
the recombinant viruses are indicated in Table 2. Recom-
binant BAC DNA was isolated and electroporated into
10.1 fibroblasts to produce viral stocks. Multi-step growth
analysis was performed by infecting 10.1 fibroblasts at a
multiplicity of infection (MOI) of 0.05, collecting super-
natant every 24 hours for five days starting at time zero,
and titrating the supernatant by plaque assay or TCID50
assay on 10.1 fibroblasts.
Table 2 Primers used for recombinant virus production
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RACE products were cloned into pGEM-T-Easy (Promega)
and sequenced. Reporter constructs were generated by
PCR amplifying sequence upstream of the 7.2 kb RNA
splice donor site. Primers used to generate the reporter
constructs are indicated in Table 1. Amplicons were re-
solved by gel electrophoresis and gel purified using the
Qiaquick Gel Extraction Kit (Qiagen). Amplicons were
cloned into pGEM-T-Easy. After insertion into the pGEM-
T-Easy plasmid, the inserts were digested from the plasmid
using the flanking EcoRI sequences then subcloned into
the pGL3 Basic vector at a newly generated EcoRI site
using the site directed mutatgenesis kit (Stratagene).
Orientation of the cloned insert was determined by se-
quencing the pGL3 plasmid. The pGL3-SV40 control
plasmid and the renilla phRL-TK normalization control
plasmid were used in the luciferase assays (Promega).
Promoter analysis
Mouse fibroblasts were seeded in 24-well dishes and
co-transfected with a pGL3 construct (see above) and
phRL-TK using polyethylenimine (PEI) at a 6:1 ratio of
PEI to plasmid DNA. The plasmids were cotransfected
at a 1:1 ratio with 3 × 1010 copies per well of each plas-
mid. Protein lysates were harvested 48 hours post trans-
fection and assayed following the Duo-Glow Luciferase
assay kit (Promega, Madison, WI). Luciferase activity
was normalized to renilla activity in each well and the
data is expressed as the fold change of luciferase induc-
tion relative to the luciferase induction from the pGL3
promoter-less vector.
RNA analyses
To determine expression kinetics, 10.1 fibroblasts were
pretreated with 100 μg/mL cyclohexamide or 200 μg/mLPAA 1 hour before MCMV infection. Total RNA was
harvested from 10.1 fibroblasts at either 24 hours post
infection (h p.i.) or 48 h p.i. with TRIzol LS (Life Tech-
nologies) according to the manufacturer’s protocol. RNA
was resolved on either a 1.4% or 0.7% glyoxal gel for de-
tection of the spliced mRNA or 7.2 kb RNA respectively.
Northern blot analysis for intron locus RNAs was car-
ried out as previously described using specific radio-
labeled riboprobes [14].
RNA half-life analysis was performed by infecting fibro-
blasts with wild-type MCMVat an MOI of 1.0. At 30 hours
post infection, 4 ug/mL Actinomycin D was added to in-
fected cells and RNA was harvested over a time course
starting at time 0 and ending at 32 hours post treatment.
Transcript levels were quantified by qRT-PCR at the
different times points relative to RNA at time 0.
5′ and 3′ RACE
Total RNA harvested from mock or WT MCMV in-
fected 10.1 mouse fibroblasts at 48 hours post infection
was analyzed by the First Choice RNA ligase-mediated
rapid amplification of cDNA ends kit as recommended
by the manufacturer (RLM-RACE, Ambion). Amplifica-
tion products were purified and TA cloned into pGEM-
T-Easy (Promega, Madison, WI) and sequenced (Table 1).
For 3′ RACE, RNA was reverse transcribed using a poly
(A)-adapter. Amplification products were cloned and se-
quenced. MacVector software was used to align RACE
sequences to MCMV reference sequence.
Primer extension
Oligonucleotides 497 and 50 were end radiolabeled and
used in primer extension reactions on total RNA from
mock- or MCMV-infected cells as previously described
(Table 1) [19]. Primer extension products were analyzed
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esis followed by phosphorimager analysis.
qRT-PCR and qPCR
Total RNA was DNase treated and reverse transcribed
using the Quantitect Reverse Transcription kit (Qiagen).
Quantitative PCR was performed using the LightCycler
480 Probes Master Mix (Roche) along with IDT hydrolysis
probes specific for the intron locus RNAs and selected
housekeeping genes (Table 1). Ct values were determined
using the Basic Relative Quantification analysis module of
the LightCycler 480 (Roche) software. Primer-probe effi-
ciencies were determined by three biological replicates of
10-fold dilutions. The 18S rRNA was used as a reference
gene and the relative target levels were quantified by a
delta-delta CT method, the Pfaffl method, that incorporates
the calculated primer-probe efficiencies (Table 1) [48].
Immunoblotting
Cells were trypsinized, centrifuged, and collected in PBS.
Cells were lysed in RIPA buffer (150 mM NaCl, 1% v/v
Nonidet P-40, 0.5% w/v deoxycholate, 0.1% w/v SDS,
5 mM EDTA, 50 mM Tris; pH 8.0) containing protease
inhibitor cocktail (Roche). The cell lysate was briefly
sonicated to facilitate nuclear protein release and insol-
uble debris was centrifuged. GFP tagged m106 protein
was immunoblotted using a rabbit polyclonal antibody
and detected with a fluorescently conjugated secondary
antibody using the SuperSignal West Pico Chemilumin-
escent Substrate (Thermo Scientific). HP1, heterochro-
matin associated protein 1, was detected similarly as a
loading control (Santa Cruz).
FISH and Immunofluorescence
Fluorescently labeled RNA probes antisense to the
7.2 kb intron were generated using the FISH Tag kit
(Table 1) (Invitrogen). Briefly, probes were in vitro tran-
scribed from linearized pGEM-T-Easy constructs using
an amino allyl modified base in which an alexa flour can
be chemically attached to. Following in vitro transcrip-
tion of the probes, the DNA templates are digested using
DNase I and the amino modified RNA is purified over a
column then ethanol precipitated. The purified probes
are fluorescently labeled according to the manufacturer’s
instructions then column purified and subsequent etha-
nol precipitation. Cells were fixed for 20 minutes in 4%
paraformaldehyde, 10% acetic acid in 1x PBS. The fix-
ation was quenched for 20 minutes in PBS with 0.1 M
glycine. Cells were washed twice with PBS then perme-
abilized with 70% ethanol overnight at 4°C. Cells were
rehydrated by washing twice with 50% formamide/2x
SSC. The probe was denatured by heating at 65°C for
10 minutes in probe buffer then cells were incubated over-
night with the denatured probe at 37°C. The followingday, cells were washed twice with 0.1X SSC/50% formam-
ide at 50°C then washed once with PBST. Immunofloures-
cence of m106-GFP was carried out as previously
described [49].
Mice
All animal procedures were approved by the Institu-
tional Animal Care and Use Committee of the University
of Colorado Denver. BALB/c mice were inoculated by
intraperitoneal injection with 5×106 pfu of tissue culture
derived wild type or recombinant MCMV in 300 ul
DMEM. At designated times mice were sacrificed and
liver, spleen, lungs, kidneys, and salivary glands were re-
moved and weighed. Part of the tissue was homogenized
and titrated on mouse fibroblasts. The remaining tissue
was processed for DNA isolation in order to quantify
viral genomes using the DNeasy Blood and Tissue kit ac-
cording to the manufacturer’s protocol (Qiagen). 250 ng
of DNA was analyzed by qPCR for each sample.
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